Search Clinical Trials
589,087 trials
ID
Status
Phase
Title
Sponsor
NCT07644286
A Phase II Study of Pirfenidone Plus PD-1 Inhibitor With or Without Hypofractionated Radiotherapy for Refractory pMMR/MSS Colorectal CancerTao ZhangRecruitingPhase 2
NCT07644286Recruiting
Phase 2
A Phase II Study of Pirfenidone Plus PD-1 Inhibitor With or Without Hypofraction...Tao Zhang
NCT07644897
Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced MelanomaSun Yat-sen UniversityRecruitingPhase 2
NCT07644897Recruiting
Phase 2
Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients...Sun Yat-sen University
NCT07644546
Immunogenicity of MF59-adjuvanted Versus High-dose Influenza Vaccine in People With HIV: a Randomized Clinical TrialNational Taiwan University HospitalNot Yet RecruitingNot Applicable
NCT07644546Not Yet Recruiting
Not Applicable
Immunogenicity of MF59-adjuvanted Versus High-dose Influenza Vaccine in People W...National Taiwan Universit...
NCT07644949
Self-Help Plus (SH+) for Stress Reduction in Social Service Workers: A Pilot RCTIstanbul Medeniyet UniversityNot Yet RecruitingNot Applicable
NCT07644949Not Yet Recruiting
Not Applicable
Self-Help Plus (SH+) for Stress Reduction in Social Service Workers: A Pilot RCTIstanbul Medeniyet Univer...
NCT07644819
Preoperative Outreach to Improve Surgical AttendanceUniversity of California, San FranciscoNot Yet RecruitingNot Applicable
NCT07644819Not Yet Recruiting
Not Applicable
Preoperative Outreach to Improve Surgical AttendanceUniversity of California,...
NCT07646054
Digital Lifestyle Coaching for Alzheimer's Disease Prevention in APOE4 Carriers23andMe, Inc.Not Yet RecruitingNot Applicable
NCT07646054Not Yet Recruiting
Not Applicable
Digital Lifestyle Coaching for Alzheimer's Disease Prevention in APOE4 Carriers23andMe, Inc.
NCT07645976
Home Environmental Risks and Caregiver AwarenessMarmara University Pendik Training and Research HospitalCompleted
NCT07643961
Outpatient Versus Inpatient Management of Mild Acute PancreatitisCenter for Traumatology and Major Burns, Ben ArousNot Yet RecruitingNot Applicable
NCT07643961Not Yet Recruiting
Not Applicable
Outpatient Versus Inpatient Management of Mild Acute PancreatitisCenter for Traumatology a...
NCT07645716
Evaluation of Interactions and Group Processes in Multidisciplinary Tumor Boards in Gynecologic OncologyFondazione Policlinico Universitario Agostino Gemelli IRCCSNot Yet Recruiting
NCT07645716Not Yet Recruiting
—
Evaluation of Interactions and Group Processes in Multidisciplinary Tumor Boards...Fondazione Policlinico Un...
NCT07644715
AI-powered ECG Analysis for Deadly Arrhythmias and ICI MyocarditisAssistance Publique - Hôpitaux de ParisRecruiting
NCT07644715Recruiting
—
AI-powered ECG Analysis for Deadly Arrhythmias and ICI MyocarditisAssistance Publique - Hôp...
NCT07646210
HiCM-188 Cell Therapy in Adults With Advanced Heart Failure Undergoing Heart Bypass SurgeryHELP Therapeutics Co., Ltd.Not Yet RecruitingPhase 1
NCT07646210Not Yet Recruiting
Phase 1
HiCM-188 Cell Therapy in Adults With Advanced Heart Failure Undergoing Heart Byp...HELP Therapeutics Co., Lt...
NCT07644065
Kynurenic Acid and Serotonin as Perioperative Neuroinflammatory Biomarkers in Sequential Third Molar SurgeryMariya Vlado Ivanovska, Dept. of Microbiology and Immunology, Faculty of Medicine, MU-PlovdivCompletedNot Applicable
NCT07644065Completed
Not Applicable
Kynurenic Acid and Serotonin as Perioperative Neuroinflammatory Biomarkers in Se...Mariya Vlado Ivanovska, D...
NCT07643805
Single-Arm Clinical Study of EZH2i in Combination With Glofitamab + GemOx in Patients With Relapsed/ Refractory DLBCLThe First Affiliated Hospital with Nanjing Medical UniversityNot Yet RecruitingPhase 1
NCT07643805Not Yet Recruiting
Phase 1
Single-Arm Clinical Study of EZH2i in Combination With Glofitamab + GemOx in Pat...The First Affiliated Hosp...
NCT07644494
Distensibility Index of Inferior Vena Cava in Assessing Fluid Responsiveness: The Impact of Spontaneous Respiratory EffortJingyuan,XuCompleted
NCT07644494Completed
—
Distensibility Index of Inferior Vena Cava in Assessing Fluid Responsiveness: Th...Jingyuan,Xu
NCT07644104
Efficacy and Safety of the Visual Bronchial Blocker for Lung Isolation SurgeryZhejiang UniversityNot Yet RecruitingNot Applicable
NCT07644104Not Yet Recruiting
Not Applicable
Efficacy and Safety of the Visual Bronchial Blocker for Lung Isolation SurgeryZhejiang University
NCT07644767
Adjunctive Oral KET-AD Capsules in Treatment Resistant Bipolar DepressionNeurocentrx Pharma Pty LtdNot Yet RecruitingPhase 2
NCT07644767Not Yet Recruiting
Phase 2
Adjunctive Oral KET-AD Capsules in Treatment Resistant Bipolar DepressionNeurocentrx Pharma Pty Lt...
NCT07643857
Circular Staplers and Anastomotic Leak After Colorectal SurgeryAzienda Ospedaliera Bolognini di Seriate BergamoNot Yet Recruiting
NCT07643857Not Yet Recruiting
—
Circular Staplers and Anastomotic Leak After Colorectal SurgeryAzienda Ospedaliera Bolog...
NCT07644247
STudy of Aspirin Removal in Patients Supported by the Fully Magnetically Levitated CH-VAD PumpBeijing Anzhen HospitalNot Yet RecruitingPhase 4
NCT07644247Not Yet Recruiting
Phase 4
STudy of Aspirin Removal in Patients Supported by the Fully Magnetically Levitat...Beijing Anzhen Hospital
NCT07645690
The Safety and Efficacy of Allogeneic CD70 CAR-T Therapy in Unresectable or Metastatic Clear Cell Renal Cell CarcinomaChinese PLA General HospitalRecruitingEarly Phase 1
NCT07645690Recruiting
Early Phase 1
The Safety and Efficacy of Allogeneic CD70 CAR-T Therapy in Unresectable or Meta...Chinese PLA General Hospi...
NCT07646483
Clinical Trial to Evaluate the Efficacy and Safety of Conjuran® After First and Second Cycle (Repeat) Administration in Patients With Knee OsteoarthritisPharmaResearch Co.,LtdNot Yet RecruitingNot Applicable
NCT07646483Not Yet Recruiting
Not Applicable
Clinical Trial to Evaluate the Efficacy and Safety of Conjuran® After First and...PharmaResearch Co.,Ltd
Result Breakdown
Not yet recruiting13 (65%)
Recruiting4 (20%)
Completed3 (15%)
not_applicable8 (40%)
Not Specified5 (25%)
Phase 23 (15%)
Phase 12 (10%)
Phase 41 (5%)
Early Phase 11 (5%)